Sanjay Shukla, President and CEO at aTYR PHARMA INC (LIFE), bought 20,000 shares at $1.81 ($36K) on 2024-05-31, disclosed to the SEC on 2024-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LIFE | BUY | 2023-11-13 | $17K | — | Filing → |
| LIFE | BUY | 2023-08-01 | $30K | — | Filing → |
| LIFE | BUY | 2022-11-21 | $21K | — | Filing → |